Nūhou

NEW YORK, Iune 23, 2022 (GLOBE NEWSWIRE) - Hoʻolaha ʻo Reportlinker.com i ka hoʻokuʻu ʻana o ka hōʻike "Global Intravenous Therapy and Intravenous Access Market Size, Share and Industry Trends Analysis Report, Outlook and Forecast by End User, Application, Type, Region, 2022-2028″ https://www.reportlinker.com/p06283441/?utm_source=GNW ʻO ke ala wikiwiki loa e hoʻokomo i ka wai i nā ʻāpana like ʻole o ke kino ma o IV therapy. ʻO ka hoʻouka ʻana o ka naʻau, ka hahau ʻana, a me ka ʻona ua mālama ʻia me kēia lāʻau. ʻO ka lāʻau lapaʻau a me ka wai i loko o ke kino ma o ke aʻa. ʻO nā lāʻau i loaʻa nā huaora a me nā minela e hāʻawi ʻia ma ka intravenous drip a intravenous injection, e hiki ai i ka lāʻau ke kahe koke i ke kahe koko. ʻO ka lapaʻau IV ke ala maʻamau e hāʻawi ai i nā wai, nā lāʻau lapaʻau, ka chemotherapy, a me ka hoʻokahe koko i nā poʻe maʻi dehydrated. I ka wā o ka lawelawe ʻana o IV, ua hoʻohana ʻia nā mea like ʻole IV e like me IV catheters, pump infusion, immobilization device, a me nā pahu hoʻokele. Ke manaʻo ʻia e hoʻonui ʻia ka mākeke intravenous therapy a me intravenous access device ma luna o ka wā wānana. ʻO ka laha ʻana o ka maʻi maʻi, ka piʻi ʻana o nā ulia pōpilikia, a me ka hoʻonui ʻana i nā kaʻina hana i manaʻo ʻia e hoʻolalelale i ka ʻoihana i mua. I nā poʻe maʻi me ka maʻi maʻi maʻi ʻehaʻeha pili i ka COVID-19, lawelawe ʻia ka IV therapy (ARDS). piʻi ka nui o ka poʻe maʻi me COVID-19-pili ARDS, piʻi ka noi no ka IV therapy a me nā huahana intravenous access. I nā makahiki e hiki mai ana, ʻo ka piʻi nui ʻana o nā maʻi maʻi e like me ka maʻi cardiovascular, cancer, stroke, a me ka maʻi diabetes, i hui pū ʻia me ka poʻe ʻelemakule, e hoʻonui i ka pono no ka intravenous therapy. i kēlā me kēia lā e nā limahana olakino e pili ana i ka mālama ʻana i ka maʻi ma ke keʻena mālama koʻikoʻi, ua hoʻololi nui ʻia ke kahua o ka mālama ma muli o ka hoʻohui ʻana o nā ʻenehana hou, a ʻo ka ʻoki ʻana i ka infusion pumps kekahi o nā kumuwaiwai ʻenehana e kōkua ai i ka hoʻomaʻamaʻa ʻana i ka hana intravenous therapy (IVT) palekana Hoʻohui hou, ʻo ka hoʻomanaʻo ʻana o ka huahana ma muli o nā hemahema o ka hana ʻana e hoʻolōʻihi i ka hoʻohana ʻana i kēia mau lāʻau lapaʻau. Me ka hoʻohana ʻana i nā ʻano IV a me nā huahana infusion IV. End User Outlook Ma muli o ka mea hoʻohana hope, ua hoʻokaʻawale ʻia ka mākeke i loko o nā haukapila, nā keʻena ʻoihana ambulatory, a me nā keʻena. Intravenous therapy in the hospitals, which includes intravenous antibiotic therapy, drug for comatose people, drugs that cannot be taken oral, interventional radiology, anticancer drugs, hemodialysis, repeat blood sample mapping, and blood transfusions .Ke ulu nei ka mākeke no ka IV therapy a me nā mea komo venous ma muli o ka holomua ʻenehana a me ka hoʻopukapuka halemai. I ka makahiki 2021, e loaʻa i ka ʻāpana Volume Expander ka loaʻa kālā nui ma ka intravenous (IV) therapy and venous access market. ʻO nā hoʻokūkū hoʻokele WADA. No ka hapa nui o nā mea pāʻani, ʻaʻole ʻo ka hoʻomaʻamaʻa maʻamau IV ka koho maikaʻi loa. catheters i ka wā o ke kaʻina hana no ka IV therapy a i ka wā o ka hoʻoili ʻana o ke koko, nā lāʻau lapaʻau, a me nā meaʻai ʻē aʻe i nā wahi like ʻole o ke kino. Hiki mai nā catheters intravenous i nā ʻano nui a me nā ʻano, e pili ana i kā lākou manaʻo e hoʻohana ai. ka ulu ʻana o nā ulia pōpilikia, ka ulu kiʻekiʻe o nā hihia trauma, a me ka hoʻonui ʻana i nā hoʻopukapuka federal i ka hoʻomohala ʻana i nā keʻena olakino maikaʻi a me nā hana R&D. Ua uhi ʻia ka hōʻike noiʻi mākeke i ka nānā ʻana o nā mea kuleana nui o ka mākeke. ʻO Smiths Group PLC a me AngioDynamics, Inc. Hoʻolālā i nā hoʻolālā i ka Intravenous (IV) Therapy a me Intravenous Access Market Malaki 2022: Ua kau inoa ʻo Fresenius Kabi i kahi ʻaelike e loaʻa iā Fresenius Kabi, kahi hui mālama ola honua. i nā halemai US.December 2021: Hoʻokumu ʻo Baxter i ka hui pū ʻana me ka mea lawelawe ʻenehana lapaʻau ʻAmelika ʻo Hillrom. E hāʻawi ʻo Smiths Medical i nā hoʻopukapuka hoʻolālā i nā hui lōʻihi i hoʻolālā ʻia e hoʻololi i ka hoʻokele hui ʻana a hoʻonui i ke olakino maʻi, ʻoiai e hālāwai ana i nā pono o nā mea mālama olakino. pili me peripheral IV therapy.Iulai 2019: Loaʻa iā Baxter ka ʻae ʻia ʻana o ka US Food and Drug Administration (FDA) no Myxredlin. ʻO ka ʻae ʻia e hiki ai i ka insulin koke no ka infusion intravenous i loko o nā halemai a me nā wahi mālama koʻikoʻi ʻē aʻe a he 30 mau lā a i ʻole 24 mau mahina ma ka lumi wela ke hoʻopaʻa ʻia i loko o ka hale hoʻomaha. Nā Hale Hana Hana • Nā Hale Hana ma ka noi • Hoʻoponopono Lapaʻau • Nā Huahana Koko • Nā meaʻai a me nā mea hoʻoponopono paʻa • Nā Waʻa Diffusion ma ke ʻano • Intravenous Catheters • Infusion Pumps • Hypodermic Needles • Implantable Ports • Other by Geography • North America o USo Canadao Mekiko Ka hoomaha o ʻAmelika ʻĀkau • ʻEuropa Kelemānia o UKo France Spain Italia o Kina o ʻEulopa ʻAsia Pākīpika • ʻAnelani ʻAmelika o Kina o ʻEulopa Korea • ʻAmelika Hui Pū ʻIa. UAE Saudi Arabia South Africa Nigeria LAMEA Rest Company Profile• B. Braun Melsungen AG • Medtronic PLC• Terumo Corporation• Fresenius SE & Co. KGaA• Cardinal Health, Inc.• Pfizer, Inc.• Teleflex, Inc.• Baxter International, Inc.• Smiths Group PLC• AngioDynamics, Inc. Loaʻa ke kumu hoʻohālike • Kūʻai ʻia ke kumu kūʻai maikaʻi loa • Hoʻopaʻa ʻia ka noiʻi ma hope o ke kūʻai ʻana i kākoʻo ʻia e 10% Customization E heluhelu i ka hōʻike piha no ka manuahi: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution.Reportlinker loaʻa a hoʻonohonoho pono iā ʻoe ke loaʻa ka ʻikepili ʻoihana hou loa i ka mākeke noiʻi._______________